HERA crosses over

Lancet Oncol. 2011 Mar;12(3):203-4. doi: 10.1016/S1470-2045(11)70039-0. Epub 2011 Feb 25.
No abstract available

Publication types

  • Comment

MeSH terms

  • Antibodies, Monoclonal / therapeutic use*
  • Antibodies, Monoclonal, Humanized
  • Antineoplastic Agents / therapeutic use*
  • Breast Neoplasms / drug therapy*
  • Breast Neoplasms / metabolism
  • Female
  • Humans
  • Randomized Controlled Trials as Topic
  • Receptor, ErbB-2*
  • Trastuzumab

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Antineoplastic Agents
  • ERBB2 protein, human
  • Receptor, ErbB-2
  • Trastuzumab